XL880
Term · Oncology and biomedicine · MLC-T-ONC-009413
A substance being studied in the treatment of cancer. XL880 blocks enzymes involved in the growth and spread of tumor cells. It may also prevent the growth of new blood vessels that tumors need to grow. It is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called foretinib and MET/VEGFR-2 inhibitor GSK1363089.
| Identifier | MLC-T-ONC-009413 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | foretinib; MET/VEGFR-2 inhibitor GSK1363089 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-009413",
"term": "XL880",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of cancer. XL880 blocks enzymes involved in the growth and spread of tumor cells. It may also prevent the growth of new blood vessels that tumors need to grow. It is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called foretinib and MET/VEGFR-2 inhibitor GSK1363089.",
"expansions": [
"foretinib",
"MET/VEGFR-2 inhibitor GSK1363089"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/xl880/"
}
Record 17,506 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.